25 XP   0   0   10

Aldeyra The
Buy, Hold or Sell?

Let's analyse Aldeyra together

PenkeI guess you are interested in Aldeyra The. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Aldeyra The. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Aldeyra The

I send you an email if I find something interesting about Aldeyra The.

Quick analysis of Aldeyra (30 sec.)










What can you expect buying and holding a share of Aldeyra? (30 sec.)

How much money do you get?

How much money do you get?
$0.02
When do you have the money?
1 year
How often do you get paid?
2.5%

What is your share worth?

Current worth
$2.02
Expected worth in 1 year
$1.48
How sure are you?
30.0%

+ What do you gain per year?

Total Gains per Share
$-0.52
Return On Investment
-13.4%

For what price can you sell your share?

Current Price per Share
$3.91
Expected price per share
$1.46 - $4.96
How sure are you?
50%

1. Valuation of Aldeyra (5 min.)




Live pricePrice per Share (EOD)

$3.91

Intrinsic Value Per Share

$-5.25 - $4.14

Total Value Per Share

$-3.23 - $6.17

2. Growth of Aldeyra (5 min.)




Is Aldeyra growing?

Current yearPrevious yearGrowGrow %
How rich?$119.7m$169.4m-$41.9m-32.9%

How much money is Aldeyra making?

Current yearPrevious yearGrowGrow %
Making money-$9.2m-$15.3m$6.1m66.6%
Net Profit Margin-302.6%0.0%--

How much money comes from the company's main activities?

3. Financial Health of Aldeyra (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#345 / 1010

Most Revenue
#631 / 1010

Most Profit
#545 / 1010

Most Efficient
#679 / 1010

What can you expect buying and holding a share of Aldeyra? (5 min.)

Welcome investor! Aldeyra's management wants to use your money to grow the business. In return you get a share of Aldeyra.

What can you expect buying and holding a share of Aldeyra?

First you should know what it really means to hold a share of Aldeyra. And how you can make/lose money.

Speculation

The Price per Share of Aldeyra is $3.91. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Aldeyra.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Aldeyra, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $2.02. Based on the TTM, the Book Value Change Per Share is $-0.14 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.23 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Aldeyra.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.08-2.1%-0.16-4.1%-0.26-6.7%-0.22-5.6%-0.15-3.9%
Usd Book Value Change Per Share-0.06-1.6%-0.14-3.5%-0.23-5.9%0.030.7%0.051.3%
Usd Dividend Per Share0.020.5%0.000.1%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.04-1.1%-0.13-3.3%-0.23-5.9%0.030.7%0.051.3%
Usd Price Per Share3.51-7.13-5.18-6.61-6.67-
Price to Earnings Ratio-10.93--11.52--5.14--8.20--15.89-
Price-to-Total Gains Ratio-79.92--61.29--23.68--31.78--29.96-
Price to Book Ratio1.73-3.25-1.84-3.93-11.75-
Price-to-Total Gains Ratio-79.92--61.29--23.68--31.78--29.96-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share3.91
Number of shares255
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.140.03
Usd Total Gains Per Share-0.130.03
Gains per Quarter (255 shares)-33.327.28
Gains per Year (255 shares)-133.2829.10
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
14-138-14312819
29-276-27625648
313-413-40938577
418-551-5424113106
522-689-6754141135
627-827-8085169164
731-964-9416197193
836-1102-10747226222
940-1240-12078254251
1045-1378-13409282280

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%0.040.00.00.0%2.043.00.04.4%
Book Value Change Per Share0.04.00.00.0%2.010.00.016.7%4.016.00.020.0%12.028.00.030.0%14.029.02.031.1%
Dividend per Share1.00.03.025.0%1.00.011.08.3%1.00.019.05.0%1.00.039.02.5%1.00.044.02.2%
Total Gains per Share0.04.00.00.0%2.010.00.016.7%4.016.00.020.0%12.028.00.030.0%14.029.02.031.1%

Fundamentals of Aldeyra

About Aldeyra The

Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated diseases. Its lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases. The company also develops ADX-629, an orally administered RASP modulator for treatment of COVID-19, atopic asthma, psoriasis, and alcohol intoxication; and ADX-2191, a dihydrofolate reductase inhibitor for the treatment retinitis pigmentosa, as well as rare retinal diseases characterized by inflammation and vision loss. In addition, it develops ADX-246 in systemic immune-mediated disease; and ADX-248 in geographic atrophy. The company was formerly known as Aldexa Therapeutics, Inc. and changed its name to Aldeyra Therapeutics, Inc. in March 2014. Aldeyra Therapeutics, Inc. was incorporated in 2004 and is based in Lexington, Massachusetts.

Fundamental data was last updated by Penke on 2024-04-11 00:05:02.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is underpriced.

1.1. Profitability of Aldeyra The.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Aldeyra earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Aldeyra to the Biotechnology industry mean.
  • A Net Profit Margin of -1,210.6% means that $-12.11 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Aldeyra The:

  • The MRQ is -1,210.6%. The company is making a huge loss. -2
  • The TTM is -302.6%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-1,210.6%TTM-302.6%-907.9%
TTM-302.6%YOY--302.6%
TTM-302.6%5Y-60.5%-242.1%
5Y-60.5%10Y4.4%-64.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-1,210.6%-200.1%-1,010.5%
TTM-302.6%-216.8%-85.8%
YOY--288.3%+288.3%
5Y-60.5%-449.1%+388.6%
10Y4.4%-605.5%+609.9%
1.1.2. Return on Assets

Shows how efficient Aldeyra is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Aldeyra to the Biotechnology industry mean.
  • -3.2% Return on Assets means that Aldeyra generated $-0.03 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Aldeyra The:

  • The MRQ is -3.2%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -5.9%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-3.2%TTM-5.9%+2.6%
TTM-5.9%YOY-7.7%+1.8%
TTM-5.9%5Y-10.4%+4.5%
5Y-10.4%10Y-12.8%+2.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.2%-13.3%+10.1%
TTM-5.9%-12.8%+6.9%
YOY-7.7%-11.7%+4.0%
5Y-10.4%-13.9%+3.5%
10Y-12.8%-15.7%+2.9%
1.1.3. Return on Equity

Shows how efficient Aldeyra is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Aldeyra to the Biotechnology industry mean.
  • -4.0% Return on Equity means Aldeyra generated $-0.04 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Aldeyra The:

  • The MRQ is -4.0%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -7.1%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-4.0%TTM-7.1%+3.1%
TTM-7.1%YOY-9.0%+1.9%
TTM-7.1%5Y-13.4%+6.3%
5Y-13.4%10Y-16.0%+2.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-4.0%-16.9%+12.9%
TTM-7.1%-16.1%+9.0%
YOY-9.0%-15.1%+6.1%
5Y-13.4%-19.3%+5.9%
10Y-16.0%-20.2%+4.2%

1.2. Operating Efficiency of Aldeyra The.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Aldeyra is operating .

  • Measures how much profit Aldeyra makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Aldeyra to the Biotechnology industry mean.
  • An Operating Margin of -1,553.1% means the company generated $-15.53  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Aldeyra The:

  • The MRQ is -1,553.1%. The company is operating very inefficient. -2
  • The TTM is -388.3%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-1,553.1%TTM-388.3%-1,164.8%
TTM-388.3%YOY--388.3%
TTM-388.3%5Y-77.7%-310.6%
5Y-77.7%10Y-4.4%-73.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-1,553.1%-296.2%-1,256.9%
TTM-388.3%-232.5%-155.8%
YOY--298.2%+298.2%
5Y-77.7%-492.1%+414.4%
10Y-4.4%-632.4%+628.0%
1.2.2. Operating Ratio

Measures how efficient Aldeyra is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 15.53 means that the operating costs are $15.53 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Aldeyra The:

  • The MRQ is 15.531. The company is inefficient in keeping operating costs low. -1
  • The TTM is 3.883. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ15.531TTM3.883+11.648
TTM3.883YOY-+3.883
TTM3.8835Y0.777+3.106
5Y0.77710Y0.043+0.733
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ15.5313.231+12.300
TTM3.8833.310+0.573
YOY-3.890-3.890
5Y0.7775.739-4.962
10Y0.0437.876-7.833

1.3. Liquidity of Aldeyra The.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Aldeyra is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 6.44 means the company has $6.44 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Aldeyra The:

  • The MRQ is 6.440. The company is very able to pay all its short-term debts. +2
  • The TTM is 8.427. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ6.440TTM8.427-1.988
TTM8.427YOY11.393-2.966
TTM8.4275Y12.401-3.973
5Y12.40110Y12.462-0.061
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ6.4403.890+2.550
TTM8.4274.173+4.254
YOY11.3935.344+6.049
5Y12.4016.126+6.275
10Y12.4626.448+6.014
1.3.2. Quick Ratio

Measures if Aldeyra is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Aldeyra to the Biotechnology industry mean.
  • A Quick Ratio of 6.42 means the company can pay off $6.42 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Aldeyra The:

  • The MRQ is 6.416. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 8.269. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ6.416TTM8.269-1.853
TTM8.269YOY16.701-8.432
TTM8.2695Y17.432-9.163
5Y17.43210Y16.988+0.444
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ6.4163.514+2.902
TTM8.2693.998+4.271
YOY16.7015.380+11.321
5Y17.4326.105+11.327
10Y16.9886.404+10.584

1.4. Solvency of Aldeyra The.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Aldeyra assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Aldeyra to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.19 means that Aldeyra assets are financed with 19.2% credit (debt) and the remaining percentage (100% - 19.2%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Aldeyra The:

  • The MRQ is 0.192. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.177. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.192TTM0.177+0.016
TTM0.177YOY0.147+0.029
TTM0.1775Y0.187-0.010
5Y0.18710Y0.192-0.005
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1920.339-0.147
TTM0.1770.336-0.159
YOY0.1470.271-0.124
5Y0.1870.366-0.179
10Y0.1920.389-0.197
1.4.2. Debt to Equity Ratio

Measures if Aldeyra is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Aldeyra to the Biotechnology industry mean.
  • A Debt to Equity ratio of 23.8% means that company has $0.24 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Aldeyra The:

  • The MRQ is 0.238. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.215. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.238TTM0.215+0.023
TTM0.215YOY0.173+0.042
TTM0.2155Y0.244-0.029
5Y0.24410Y0.197+0.047
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2380.388-0.150
TTM0.2150.402-0.187
YOY0.1730.335-0.162
5Y0.2440.426-0.182
10Y0.1970.461-0.264

2. Market Valuation of Aldeyra The

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Aldeyra generates.

  • Above 15 is considered overpriced but always compare Aldeyra to the Biotechnology industry mean.
  • A PE ratio of -10.93 means the investor is paying $-10.93 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Aldeyra The:

  • The EOD is -12.174. Based on the earnings, the company is expensive. -2
  • The MRQ is -10.929. Based on the earnings, the company is expensive. -2
  • The TTM is -11.518. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-12.174MRQ-10.929-1.245
MRQ-10.929TTM-11.518+0.589
TTM-11.518YOY-5.137-6.381
TTM-11.5185Y-8.204-3.314
5Y-8.20410Y-15.888+7.684
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-12.174-2.264-9.910
MRQ-10.929-2.629-8.300
TTM-11.518-2.680-8.838
YOY-5.137-4.145-0.992
5Y-8.204-6.257-1.947
10Y-15.888-6.254-9.634
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Aldeyra The:

  • The EOD is 115.626. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is 103.798. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is 16.698. Based on how much money comes from the company's main activities, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD115.626MRQ103.798+11.829
MRQ103.798TTM16.698+87.100
TTM16.698YOY-5.853+22.551
TTM16.6985Y-4.144+20.842
5Y-4.14410Y-19.569+15.425
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD115.626-2.973+118.599
MRQ103.798-3.333+107.131
TTM16.698-3.553+20.251
YOY-5.853-5.605-0.248
5Y-4.144-8.376+4.232
10Y-19.569-8.865-10.704
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Aldeyra is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 1.73 means the investor is paying $1.73 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Aldeyra The:

  • The EOD is 1.932. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.734. Based on the equity, the company is underpriced. +1
  • The TTM is 3.251. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD1.932MRQ1.734+0.198
MRQ1.734TTM3.251-1.516
TTM3.251YOY1.844+1.407
TTM3.2515Y3.931-0.680
5Y3.93110Y11.755-7.824
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD1.9321.896+0.036
MRQ1.7342.115-0.381
TTM3.2512.093+1.158
YOY1.8442.884-1.040
5Y3.9313.542+0.389
10Y11.7553.916+7.839
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Aldeyra The.

3.1. Institutions holding Aldeyra The

Institutions are holding 60.643% of the shares of Aldeyra The.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Perceptive Advisors LLC14.59120.67338593586-2756499-24.2862
2023-12-31Knoll Capital Management LP9.29715.91515475516244360180.596
2023-12-31Vanguard Group Inc6.66870.0003392759774017723.2218
2023-12-31BlackRock Inc5.82520.00033430774596421.7692
2023-12-31Verition Fund Managegment, LLC2.24950.0364132483438956141.6521
2023-12-31Kennedy Capital Management Inc2.16680.0978127614612761460
2023-09-30LAURION CAPITAL MANAGEMENT LP1.91680.046112888912751212.7337
2023-12-31Dimensional Fund Advisors, Inc.1.76350.00111038652-166372-13.8065
2023-12-31Geode Capital Management, LLC1.73620.00041022572470004.8177
2023-12-31Eagle Asset Management, Inc.1.71550.0191010334-32061-3.0757
2023-12-31State Street Corporation1.52640.0002899009-2166958-70.6778
2023-12-31Millennium Management LLC0.74770.0007440388-141790-24.3551
2023-12-31Morgan Stanley - Brokerage Accounts0.71320.000142006817095368.6241
2023-12-31Northern Trust Corp0.66730.0003393007-19437-4.7126
2023-12-31Bank of America Corp0.63490.00013739207649525.7191
2023-12-31Two Sigma Advisers, LLC0.59660.0029351400-69500-16.5122
2023-12-31Wells Fargo & Co0.5860.000334511318410.5363
2023-12-31Renaissance Technologies Corp0.50940.00163000007820035.257
2023-12-31Johnson & Johnson0.50880.024299669-95165-24.1025
2023-12-31Deutsche Bank AG0.5050.000529743626610.9027
Total 54.925716.820432348910-33993-0.1%

3.2. Funds holding Aldeyra The

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-02-29Vanguard Total Stock Mkt Idx Inv2.98160.0004175601000
2024-03-28iShares Russell 2000 ETF1.97410.005811626855610.0483
2023-12-31Kennedy Micro Cap1.95850.8542115347411534740
2023-12-31Vanguard Explorer Inv1.27930.0124753477618037456.3179
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr1.2480.002673504100
2023-12-31Eagle Small Cap Growth – Institutional0.9950.1528586014-12606-2.1058
2024-01-31Fidelity Small Cap Index0.79180.005946634129960.6466
2024-03-28iShares Russell 2000 Growth ETF0.71110.0118418833-487-0.1161
2023-12-31Carillon Eagle Small Cap Growth A0.50440.17629705600
2024-02-29State St Russell Sm/Mid Cp® Indx NL Cl C0.48410.002528510045001.6037
2024-02-29DWS ESG Biotech LC0.45350.241826707000
2024-02-29DFA US Small Cap I0.4520.0062266215-81422-23.4216
2024-02-29Fidelity Extended Market Index0.43650.0024257086-1246-0.4823
2024-02-29DFA US Micro Cap I0.42060.012524771800
2024-02-29SEI Small Cap F (SIMT)0.32420.11541909323300820.9012
2024-03-31State St Russell Sm Cap® Indx SL Cl I0.3070.006118080000
2023-12-31Vanguard Strategic Small-Cap Equity Inv0.28530.03961680581680580
2024-02-29Vanguard Russell 2000 ETF0.28350.0063166988131728.5635
2024-02-29Vanguard Health Care ETF0.27090.00281595598160.514
2024-02-29Vifag 2002 SICAV0.240.79971413394073240.4862
Total 16.40142.45729659796+1939593+20.1%

3.3. Insider Transactions

Insiders are holding 2.012% of the shares of Aldeyra The.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-04-05Perceptive Advisors LlcBUY377124.74
2024-04-03Perceptive Advisors LlcBUY3098474.09
2024-04-01Perceptive Advisors LlcBUY83743.25
2024-03-11Bruce GreenbergSELL132013.41
2024-03-11Todd C BradySELL979143.27
2023-10-18Perceptive Advisors LlcSELL3064991.74
2023-10-16Perceptive Advisors LlcSELL24500001.6

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Aldeyra The compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.062-0.135+120%-0.232+278%0.028-322%0.050-223%
Book Value Per Share--2.0242.161-6%2.878-30%2.073-2%1.268+60%
Current Ratio--6.4408.427-24%11.393-43%12.401-48%12.462-48%
Debt To Asset Ratio--0.1920.177+9%0.147+30%0.187+3%0.192+0%
Debt To Equity Ratio--0.2380.215+11%0.173+37%0.244-2%0.197+21%
Dividend Per Share--0.0180.004+300%-+100%0.001+1900%0.000+3900%
Eps---0.080-0.159+98%-0.263+228%-0.217+170%-0.152+89%
Free Cash Flow Per Share--0.008-0.129+1622%-0.240+2944%-0.180+2229%-0.123+1559%
Free Cash Flow To Equity Per Share---0.009-0.134+1450%-0.230+2561%165118.944-100%82559.510-100%
Gross Profit Margin--1.0141.003+1%1.000+1%1.001+1%1.000+1%
Intrinsic Value_10Y_max--4.143--------
Intrinsic Value_10Y_min---5.254--------
Intrinsic Value_1Y_max---0.362--------
Intrinsic Value_1Y_min---0.702--------
Intrinsic Value_3Y_max---0.496--------
Intrinsic Value_3Y_min---1.971--------
Intrinsic Value_5Y_max--0.084--------
Intrinsic Value_5Y_min---3.076--------
Market Cap230282578.000+10%207777788.010420200826.633-51%305301103.250-32%389547403.877-47%392810976.678-47%
Net Profit Margin---12.106-3.026-75%--100%-0.605-95%0.044-27556%
Operating Margin---15.531-3.883-75%--100%-0.777-95%-0.044-100%
Operating Ratio--15.5313.883+300%-+100%0.777+1900%0.043+35647%
Pb Ratio1.932+10%1.7343.251-47%1.844-6%3.931-56%11.755-85%
Pe Ratio-12.174-11%-10.929-11.518+5%-5.137-53%-8.204-25%-15.888+45%
Price Per Share3.910+10%3.5107.128-51%5.184-32%6.613-47%6.669-47%
Price To Free Cash Flow Ratio115.626+10%103.79816.698+522%-5.853+106%-4.144+104%-19.569+119%
Price To Total Gains Ratio-89.028-11%-79.921-61.294-23%-23.681-70%-31.782-60%-29.959-63%
Quick Ratio--6.4168.269-22%16.701-62%17.432-63%16.988-62%
Return On Assets---0.032-0.059+83%-0.077+140%-0.104+224%-0.128+298%
Return On Equity---0.040-0.071+79%-0.090+127%-0.134+237%-0.160+303%
Total Gains Per Share---0.044-0.131+198%-0.232+429%0.029-254%0.050-187%
Usd Book Value--119795030.000127482295.250-6%169479852.000-29%122136218.650-2%74681931.050+60%
Usd Book Value Change Per Share---0.062-0.135+120%-0.232+278%0.028-322%0.050-223%
Usd Book Value Per Share--2.0242.161-6%2.878-30%2.073-2%1.268+60%
Usd Dividend Per Share--0.0180.004+300%-+100%0.001+1900%0.000+3900%
Usd Eps---0.080-0.159+98%-0.263+228%-0.217+170%-0.152+89%
Usd Free Cash Flow--500440.000-7581532.000+1615%-14159296.750+2929%-10599845.150+2218%-7265195.875+1552%
Usd Free Cash Flow Per Share--0.008-0.129+1622%-0.240+2944%-0.180+2229%-0.123+1559%
Usd Free Cash Flow To Equity Per Share---0.009-0.134+1450%-0.230+2561%165118.944-100%82559.510-100%
Usd Market Cap230282578.000+10%207777788.010420200826.633-51%305301103.250-32%389547403.877-47%392810976.678-47%
Usd Price Per Share3.910+10%3.5107.128-51%5.184-32%6.613-47%6.669-47%
Usd Profit---4752962.000-9211549.750+94%-15342321.250+223%-12718615.850+168%-8789510.075+85%
Usd Revenue--392620.00098155.000+300%-+100%19631.000+1900%603043588914.350-100%
Usd Total Gains Per Share---0.044-0.131+198%-0.232+429%0.029-254%0.050-187%
 EOD+4 -4MRQTTM+20 -16YOY+21 -155Y+16 -2010Y+16 -20

4.2. Fundamental Score

Let's check the fundamental score of Aldeyra The based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-12.174
Price to Book Ratio (EOD)Between0-11.932
Net Profit Margin (MRQ)Greater than0-12.106
Operating Margin (MRQ)Greater than0-15.531
Quick Ratio (MRQ)Greater than16.416
Current Ratio (MRQ)Greater than16.440
Debt to Asset Ratio (MRQ)Less than10.192
Debt to Equity Ratio (MRQ)Less than10.238
Return on Equity (MRQ)Greater than0.15-0.040
Return on Assets (MRQ)Greater than0.05-0.032
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of Aldeyra The based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5052.345
Ma 20Greater thanMa 503.952
Ma 50Greater thanMa 1003.607
Ma 100Greater thanMa 2003.404
OpenGreater thanClose3.940
Total4/5 (80.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-12-312023-03-312023-06-302023-09-302023-12-31
Other Current Liabilities  14,06636814,434-5,1239,310-1,4677,843-8,307-464
Gross Profit  -670-673-64-1-65391326



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets148,327
Total Liabilities28,532
Total Stockholder Equity119,795
 As reported
Total Liabilities 28,532
Total Stockholder Equity+ 119,795
Total Assets = 148,327

Assets

Total Assets148,327
Total Current Assets143,347
Long-term Assets4,980
Total Current Assets
Cash And Cash Equivalents 142,823
Other Current Assets 524
Total Current Assets  (as reported)143,347
Total Current Assets  (calculated)143,347
+/-0
Long-term Assets
Property Plant Equipment 517
Long-term Assets Other 4,464
Long-term Assets  (as reported)4,980
Long-term Assets  (calculated)4,980
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities22,260
Long-term Liabilities6,272
Total Stockholder Equity119,795
Total Current Liabilities
Short-term Debt 15,386
Short Long Term Debt 15,147
Accounts payable 1,338
Other Current Liabilities -464
Total Current Liabilities  (as reported)22,260
Total Current Liabilities  (calculated)31,407
+/- 9,147
Long-term Liabilities
Capital Lease Obligations 511
Long-term Liabilities  (as reported)6,272
Long-term Liabilities  (calculated)511
+/- 5,761
Total Stockholder Equity
Common Stock59
Retained Earnings -394,259
Other Stockholders Equity 513,995
Total Stockholder Equity (as reported)119,795
Total Stockholder Equity (calculated)119,795
+/-0
Other
Capital Stock59
Cash and Short Term Investments 142,823
Common Stock Shares Outstanding 59,196
Current Deferred Revenue6,000
Liabilities and Stockholders Equity 148,327
Net Debt -127,166
Net Invested Capital 134,942
Net Working Capital 125,550
Property Plant and Equipment Gross 517
Short Long Term Debt Total 15,657



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-31
> Total Assets 
1,977
0
0
2,819
3,743
2,891
11,805
10,351
8,787
15,931
33,878
31,350
28,205
23,437
32,884
29,191
25,188
31,532
26,468
49,229
44,175
40,776
43,286
37,132
95,091
88,128
73,839
77,441
75,518
63,029
71,627
88,324
83,353
147,306
256,427
247,218
233,137
222,693
201,015
189,692
181,292
168,219
155,616
147,282
148,327
148,327147,282155,616168,219181,292189,692201,015222,693233,137247,218256,427147,30683,35388,32471,62763,02975,51877,44173,83988,12895,09137,13243,28640,77644,17549,22926,46831,53225,18829,19132,88423,43728,20531,35033,87815,9318,78710,35111,8052,8913,7432,819001,977
   > Total Current Assets 
1,977
0
0
2,769
3,271
2,155
11,805
10,345
8,760
15,898
33,837
31,226
28,088
23,309
32,809
29,126
25,131
31,473
26,342
49,053
43,966
40,605
43,071
36,845
94,769
86,996
72,856
77,020
75,169
62,752
71,423
88,193
83,059
147,073
256,261
246,772
232,753
222,355
200,741
189,483
181,023
168,017
155,479
147,210
143,347
143,347147,210155,479168,017181,023189,483200,741222,355232,753246,772256,261147,07383,05988,19371,42362,75275,16977,02072,85686,99694,76936,84543,07140,60543,96649,05326,34231,47325,13129,12632,80923,30928,08831,22633,83715,8988,76010,34511,8052,1553,2712,769001,977
       Cash And Cash Equivalents 
1,224
0
0
2,764
3,262
2,146
11,536
10,142
8,527
15,721
33,570
30,618
14,649
10,149
17,608
14,569
12,015
19,303
14,610
33,104
20,023
20,964
24,606
18,009
47,357
44,298
39,400
51,604
44,426
38,543
60,689
86,176
77,858
138,442
249,739
241,369
229,791
158,909
121,012
128,651
144,419
165,028
151,676
143,335
142,823
142,823143,335151,676165,028144,419128,651121,012158,909229,791241,369249,739138,44277,85886,17660,68938,54344,42651,60439,40044,29847,35718,00924,60620,96420,02333,10414,61019,30312,01514,56917,60810,14914,64930,61833,57015,7218,52710,14211,5362,1463,2622,764001,224
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
12,942
12,877
14,941
14,307
12,898
11,910
11,211
14,807
22,923
17,975
17,073
17,134
46,242
37,827
30,057
24,567
28,939
22,834
5,501
0
0
0
0
0
0
57,957
75,677
56,679
29,882
0
0
0
0
000029,88256,67975,67757,9570000005,50122,83428,93924,56730,05737,82746,24217,13417,07317,97522,92314,80711,21111,91012,89814,30714,94112,87712,942000000000000
       Net Receivables 
750
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
18,000
0
17,000
11,000
44,000
39,000
32,000
26,000
28,000
23,000
10,000
15,000
25,000
50,000
125,000
125,000
125,000
65,000
79,000
21,500
3,242
24
0
0
0
000243,24221,50079,00065,000125,000125,000125,00050,00025,00015,00010,00023,00028,00026,00032,00039,00044,00011,00017,000018,0000000000000000000000750
       Other Current Assets 
3
0
0
4
8
10
270
203
233
177
267
607
498
284
260
250
219
261
521
1,142
1,019
1,667
1,393
1,703
1,170
4,872
3,399
849
1,804
1,375
5,233
2,017
407
216
1,297
870
558
433
328
4,154
6,722
2,989
259
212
524
5242122592,9896,7224,1543284335588701,2972164072,0175,2331,3751,8048493,3994,8721,1701,7031,3931,6671,0191,1425212612192502602844986072671772332032701084003
   > Long-term Assets 
0
0
0
50
472
735
0
6
27
33
41
125
117
127
75
66
56
58
126
177
209
171
215
286
322
1,132
983
421
349
277
205
132
293
233
166
446
384
338
274
209
269
202
137
72
4,980
4,980721372022692092743383844461662332931322052773494219831,132322286215171209177126585666751271171254133276073547250000
       Property Plant Equipment 
0
0
0
0
0
0
0
6
13
13
41
88
80
81
75
66
56
58
48
38
43
171
215
243
235
594
491
421
349
277
205
132
293
233
166
446
384
338
274
209
269
202
137
72
517
517721372022692092743383844461662332931322052773494214915942352432151714338485856667581808841131360000000
       Other Assets 
0
0
0
0
472
736
0
0
14
20
0
36
36
46
0
0
0
0
78
138
166
0
0
43
87
538
492
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000049253887430016613878000046363602014007364720000
> Total Liabilities 
27,132
0
0
14,583
2,128
4,027
1,990
2,087
2,503
2,105
2,353
2,655
3,326
2,910
3,366
3,520
3,538
3,537
3,128
3,324
4,574
4,775
6,305
8,537
8,473
9,648
6,506
26,562
27,436
19,557
18,838
19,154
23,844
21,232
22,747
27,548
27,402
32,004
26,986
27,498
30,284
30,976
25,733
24,275
28,532
28,53224,27525,73330,97630,28427,49826,98632,00427,40227,54822,74721,23223,84419,15418,83819,55727,43626,5626,5069,6488,4738,5376,3054,7754,5743,3243,1283,5373,5383,5203,3662,9103,3262,6552,3532,1052,5032,0871,9904,0272,12814,5830027,132
   > Total Current Liabilities 
363
0
0
201
605
692
1,175
846
1,328
1,036
1,391
1,374
2,115
1,808
2,373
2,637
2,299
2,409
2,112
2,419
3,354
3,667
5,310
7,654
8,473
9,492
6,390
12,116
12,908
4,887
4,920
6,461
12,409
11,091
7,409
11,942
11,773
16,354
16,243
24,195
15,361
16,008
15,605
21,617
22,260
22,26021,61715,60516,00815,36124,19516,24316,35411,77311,9427,40911,09112,4096,4614,9204,88712,90812,1166,3909,4928,4737,6545,3103,6673,3542,4192,1122,4092,2992,6372,3731,8082,1151,3741,3911,0361,3288461,17569260520100363
       Short-term Debt 
167
0
0
0
143
388
407
0
78
194
310
0
78
194
310
427
78
194
310
427
116
233
349
465
0
221
212
219
226
172
1,010
2,318
3,893
5,271
118
222
230
236
5,168
12,634
1,161
1,145
6,024
13,527
15,386
15,38613,5276,0241,1451,16112,6345,1682362302221185,2713,8932,3181,010172226219212221046534923311642731019478427310194780310194780407388143000167
       Short Long Term Debt 
0
0
0
0
0
0
0
0
78
0
0
0
78
0
0
0
78
194
1,327
427
116
233
349
465
0
221
0
0
0
0
894
2,259
3,660
5,095
0
0
0
0
4,926
12,449
912
954
5,894
13,461
15,147
15,14713,4615,89495491212,4494,92600005,0953,6602,259894000022104653492331164271,32719478000780007800000000
       Accounts payable 
73
0
0
65
342
166
556
482
341
406
629
744
851
578
823
734
275
695
763
485
1,001
1,619
802
3,442
3,052
4,013
2,774
572
808
1,073
217
124
382
449
1,094
468
1,020
2,443
264
1,307
134
430
271
247
1,338
1,3382472714301341,3072642,4431,0204681,0944493821242171,0738085722,7744,0133,0523,4428021,6191,001485763695275734823578851744629406341482556166342650073
       Other Current Liabilities 
124
0
0
136
120
138
211
364
909
436
452
630
1,186
1,036
1,240
1,477
1,946
1,520
1,039
1,507
2,236
1,815
4,159
3,746
5,421
5,257
3,404
11,325
11,873
3,642
3,694
4,019
8,135
5,372
6,196
11,252
10,523
13,676
10,810
10,254
14,066
14,434
9,310
7,843
-464
-4647,8439,31014,43414,06610,25410,81013,67610,52311,2526,1965,3728,1354,0193,6943,64211,87311,3253,4045,2575,4213,7464,1591,8152,2361,5071,0391,5201,9461,4771,2401,0361,18663045243690936421113812013600124
   > Long-term Liabilities 
26,768
0
0
14,382
1,523
3,336
816
1,241
1,175
1,069
962
1,281
1,211
1,102
993
883
1,239
1,128
1,016
905
1,220
1,108
995
883
0
157
116
14,445
14,528
14,670
13,917
12,693
11,434
10,141
15,338
15,606
15,629
15,650
10,744
3,303
14,923
14,968
10,128
2,657
6,272
6,2722,65710,12814,96814,9233,30310,74415,65015,62915,60615,33810,14111,43412,69313,91714,67014,52814,44511615708839951,1081,2209051,0161,1281,2398839931,1021,2111,2819621,0691,1751,2418163,3361,52314,3820026,768
       Long term Debt Total 
0
0
0
0
0
972
816
1,241
1,175
1,069
962
1,281
1,211
1,102
993
883
1,239
1,128
1,016
905
1,220
1,108
995
883
0
0
0
14,387
14,528
14,670
13,917
12,693
11,434
10,141
15,338
15,421
15,504
15,587
10,744
3,303
14,923
14,968
0
0
0
00014,96814,9233,30310,74415,58715,50415,42115,33810,14111,43412,69313,91714,67014,52814,3870008839951,1081,2209051,0161,1281,2398839931,1021,2111,2819621,0691,1751,24181697200000
       Long term Debt 
2,535
0
0
0
4,648
972
816
1,241
1,175
1,069
962
1,281
1,211
1,102
993
883
1,239
1,128
1,016
905
1,220
1,108
995
883
0
157
0
14,387
14,528
14,670
13,917
12,693
11,434
10,141
15,338
15,421
15,504
15,587
10,744
3,303
14,923
14,968
10,128
2,657
0
02,65710,12814,96814,9233,30310,74415,58715,50415,42115,33810,14111,43412,69313,91714,67014,52814,387015708839951,1081,2209051,0161,1281,2398839931,1021,2111,2819621,0691,1751,2418169724,6480002,535
       Capital Lease Obligations 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
378
328
278
226
172
116
59
233
176
118
407
355
299
243
185
249
190
130
66
511
51166130190249185243299355407118176233591161722262783283780000000000000000000000000
       Warrants
0
0
0
0
0
77,018
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000000000000000000077,01800000
       Other Liabilities 
24,234
0
0
0
394
604
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000000000000000000060439400024,234
       Long-term Liabilities Other 
0
0
0
0
0
2,231
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
157
116
59
0
0
0
0
0
0
0
185
125
63
0
0
0
0
0
0
0
00000006312518500000005911615700000000000000000002,23100000
       Deferred Long Term Liability 
0
0
0
0
0
132
0
0
14
0
0
0
36
0
0
0
0
0
0
0
166
0
0
43
87
538
492
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000492538874300166000000036000140013200000
> Total Stockholder Equity
-25,155
0
0
-11,764
1,615
-1,137
9,815
8,264
6,284
13,827
31,525
28,695
24,878
20,527
29,518
25,672
21,650
27,995
23,340
45,905
39,601
36,001
36,981
28,595
86,618
78,480
67,333
50,879
48,082
43,473
52,790
69,170
59,509
126,074
233,680
219,670
205,736
190,689
174,029
162,194
151,008
137,243
129,883
123,008
119,795
119,795123,008129,883137,243151,008162,194174,029190,689205,736219,670233,680126,07459,50969,17052,79043,47348,08250,87967,33378,48086,61828,59536,98136,00139,60145,90523,34027,99521,65025,67229,51820,52724,87828,69531,52513,8276,2848,2649,815-1,1371,615-11,76400-25,155
   Common Stock
4
0
0
4
4
0
6
6
6
7
10
10
10
10
12
13
13
15
15
19
19
20
21
21
26
27
27
27
29
30
33
39
39
48
58
58
58
58
58
59
59
59
59
59
59
59595959595958585858584839393330292727272621212019191515131312101010107666044004
   Retained Earnings Total Equity
0
0
0
0
0
40,923
-42,058
-44,067
-46,512
-48,648
-50,880
-54,246
-58,602
-63,569
-67,872
-72,650
-77,301
-82,392
-87,701
-92,687
-99,642
-108,039
-117,089
-127,902
-138,535
-154,159
-167,486
-186,201
-199,362
-209,230
-216,750
-225,624
-236,916
-248,206
-263,143
-278,937
-294,692
-311,480
-329,261
-343,814
-356,717
-372,332
0
0
0
000-372,332-356,717-343,814-329,261-311,480-294,692-278,937-263,143-248,206-236,916-225,624-216,750-209,230-199,362-186,201-167,486-154,159-138,535-127,902-117,089-108,039-99,642-92,687-87,701-82,392-77,301-72,650-67,872-63,569-58,602-54,246-50,880-48,648-46,512-44,067-42,05840,92300000
   Accumulated Other Comprehensive Income 
0
0
0
0
0
0
-11,805
-10,351
0
0
0
0
-8
2
5
7
0
-5
-5
-1
-18
-16
-3
-5
-9
7
13
6
6
58
5
0
0
0
0
0
0
-62
-286
-286
-104
0
0
0
0
0000-104-286-286-6200000055866137-9-5-3-16-18-1-5-50752-80000-10,351-11,805000000
   Capital Surplus 
0
0
0
0
0
1,277
51,867
52,325
52,790
62,468
82,395
82,932
83,479
84,085
97,372
98,302
98,938
110,377
111,031
138,574
139,242
144,037
154,052
156,481
225,136
232,605
234,779
237,048
247,410
252,616
269,502
294,755
296,386
374,232
496,764
498,549
500,369
502,172
503,518
506,235
507,770
509,517
0
0
0
000509,517507,770506,235503,518502,172500,369498,549496,764374,232296,386294,755269,502252,616247,410237,048234,779232,605225,136156,481154,052144,037139,242138,574111,031110,37798,93898,30297,37284,08583,47982,93282,39562,46852,79052,32551,8671,27700000
   Treasury Stock000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
897
42,935
1,277
51,867
52,325
52,790
62,468
82,395
82,932
83,479
84,085
97,372
98,302
98,938
110,377
111,031
138,574
139,242
144,037
154,052
156,481
225,136
232,605
234,779
237,048
247,410
252,616
269,502
294,755
296,386
374,232
496,764
498,549
500,369
502,172
503,518
506,235
507,770
509,517
511,144
512,455
513,995
513,995512,455511,144509,517507,770506,235503,518502,172500,369498,549496,764374,232296,386294,755269,502252,616247,410237,048234,779232,605225,136156,481154,052144,037139,242138,574111,031110,37798,93898,30297,37284,08583,47982,93282,39562,46852,79052,32551,8671,27742,935897000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue0
Cost of Revenue-263
Gross Profit-263-263
 
Operating Income (+$)
Gross Profit-263
Operating Expense-42,531
Operating Income-42,794-42,794
 
Operating Expense (+$)
Research Development29,459
Selling General Administrative13,335
Selling And Marketing Expenses263
Operating Expense42,53143,057
 
Net Interest Income (+$)
Interest Income6,719
Interest Expense-2,071
Other Finance Cost-53
Net Interest Income4,701
 
Pretax Income (+$)
Operating Income-42,794
Net Interest Income4,701
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-37,543-48,046
EBIT - interestExpense = -44,866
-37,543
-35,471
Interest Expense2,071
Earnings Before Interest and Taxes (EBIT)-42,794-35,471
Earnings Before Interest and Taxes (EBITDA)-42,531
 
After tax Income (+$)
Income Before Tax-37,543
Tax Provision-0
Net Income From Continuing Ops-45,692-37,543
Net Income-37,543
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses42,794
Total Other Income/Expenses Net5,252-4,701
 

Technical Analysis of Aldeyra
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Aldeyra. The general trend of Aldeyra is BULLISH with 14.3% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Aldeyra's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (14.3%) Bearish trend (-14.3%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Aldeyra The.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 4.9541 < 4.96 < 4.96.

The bearish price targets are: 2.71 > 2.43 > 1.46.

Tweet this
Aldeyra The Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Aldeyra The. The current mas is .

The long score for the Moving Averages is 8/14.
The longshort score for the Moving Averages is 2/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Aldeyra The Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Aldeyra The. The current macd is 0.14115337.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Aldeyra price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Aldeyra. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Aldeyra price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Aldeyra The Daily Moving Average Convergence/Divergence (MACD) ChartAldeyra The Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Aldeyra The. The current adx is 27.50.

The long score for the Directional Movement Index (DMI) is 3/7.
The longshort score for the Directional Movement Index (DMI) is 3/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Aldeyra shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bullish trend. The ADX is declining, the bullish trend is weakening. Could be a potential reversal to the downside. +2
Aldeyra The Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Aldeyra The. The current sar is 4.62942643.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Aldeyra The Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Aldeyra The. The current rsi is 52.35. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 2/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending down: The RSI is trending down. -1
Aldeyra The Daily Relative Strength Index (RSI) ChartAldeyra The Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Aldeyra The. The current phase is Oversold in bull market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Aldeyra price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Aldeyra The Daily Stochastic Oscillator ChartAldeyra The Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Aldeyra The. The current cci is 6.24871866.

Aldeyra The Daily Commodity Channel Index (CCI) ChartAldeyra The Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Aldeyra The. The current cmo is -2.06330276.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Aldeyra The Daily Chande Momentum Oscillator (CMO) ChartAldeyra The Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Aldeyra The. The current willr is -89.83050847.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Aldeyra The Daily Williams %R ChartAldeyra The Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Aldeyra The.

Aldeyra The Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Aldeyra The. The current atr is 0.29394858.

Aldeyra The Daily Average True Range (ATR) ChartAldeyra The Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Aldeyra The. The current obv is 62,882,421.

Aldeyra The Daily On-Balance Volume (OBV) ChartAldeyra The Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Aldeyra The. The current mfi is 54.10.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Aldeyra The Daily Money Flow Index (MFI) ChartAldeyra The Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Aldeyra The.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-01WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-04BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-05STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-07STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-08STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-11SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-13STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-15STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-19SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-22STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-27WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-10STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-11CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-01-24STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-25DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-26DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-01-29SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-31STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-09STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-12WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-13STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-14STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-15BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-22STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-26WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-27BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-04RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-07SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-08CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-12CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-13STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-22MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-26MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-27SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-03-28MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-02WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-03CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-04STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-04-08RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-09MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-04-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-15SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-04-16CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-17MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-19CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-23WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside

6.3. Candlestick Patterns

Aldeyra The Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Aldeyra The based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5052.345
Ma 20Greater thanMa 503.952
Ma 50Greater thanMa 1003.607
Ma 100Greater thanMa 2003.404
OpenGreater thanClose3.940
Total4/5 (80.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Aldeyra with someone you think should read this too:
  • Are you bullish or bearish on Aldeyra? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Aldeyra? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Aldeyra The

I send you an email if I find something interesting about Aldeyra The.


Comments

How you think about this?

Leave a comment

Stay informed about Aldeyra The.

Receive notifications about Aldeyra The in your mailbox!